Back to Search
ROCKTON HITT, MD
MD
Family Medicine Physician
NPI: 1225108947IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
036-070971(IL)036070971(IL)
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
42236(WI)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Class of 1984
Research & Publications (20)
Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.
PMID 19065122·Ther Drug Monit·2009
8-other
Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma.
PMID 19574207·Clin Transl Oncol·2009
8-other
Coexistence of two rare sarcomas: primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver.
PMID 18382610·Sarcoma·2008
5-case
Case records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left breast and shortness of breath.
PMID 18234756·N Engl J Med·2008
5-case
CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma--a pilot study.
PMID 18234543·Oral Oncol·2008
8-other
Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
PMID 18539887·Radiology·2008
8-other
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
PMID 18784101·N Engl J Med·2008
3-trial
Primary pulmonary artery sarcoma: report of three cases and review of the literature.
PMID 17311694·Clin Lung Cancer·2007
5-case
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
PMID 17538161·J Clin Oncol·2007
3-trial
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
PMID 16896002·J Clin Oncol·2006
8-other
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
PMID 16877728·J Clin Oncol·2006
8-other
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
PMID 16717293·J Clin Oncol·2006
3-trial
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16329139·Cancer·2006
3-trial
A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy.
PMID 16149284·Clin Oncol (R Coll Radiol)·2005
4-observational
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
PMID 16275937·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 KISH HOSPITAL DR
DEKALB, IL 60115 - Phone
- (815) 766-7334
Quick Facts
- NPI
- 1225108947
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile